Notifications
Back

       About us

About us

MatrixCell Bio    is a Korean Bio Startup company giving solutions to regenerative and   reconstructive manufacture of tissue engineering products through mobile and stationary 3D bioprinting systems (bioinks, medical devices and bioprinters).


Business Area

In the area of both 3D bioprinting technology and its biopharma, our vision is to become the leading company in the field of regenerative medicine by contributing bioinks/hydrogels and tissue engineering equipment to the medical industry and academics. We have unique core technologies (biomaterials, equipment) for direct biprinting in vivo and in vitro tissue engineering regenerative medicine.


History

2024

  • 11 Stepping stone project for startup growth technology development 
  • 10 2024 Intellectual Property Startup Competition
  • 09 Invited speaker at the UNESCO-WIPO Leadership Program
  • 08 Project: “A business unit for bone replacement fusion medical devices.”
  • 08 Participate in the Bridge Forum IR Meetup
  • 05 Participate in the World Biomaterials Congress Booth
  • 04 Biodata Verification Grant

2023

  • 05 BioIcore Grant
  • 06 Approved Corporate Research Institute (Director: Dr. YoungGon Kim)

2022

          

  • Early Startup Package Business Grant

2021

  • 05 Preliminary Startup Package Business Grant
  • 10 Establishment of MatrixCell Bio Inc. at the 2nd Startup Incubation Center in the Seoul Nation University of Science and Technology.

Mission

Supply biomaterials and user-friendly equipment to the bioprinting tissue engineering academics and industry.

Vision

Leading bio-company in bioprinting tissue engineering and healthcare.

Core Value

1.Value creation

2. Solution to bioprinting tissue engineering problems.

3. Advanced bioprinting technology and biomaterials.